Acetaminophen Aspirin And Caffeine Tablet, Film Coated
Product Images NDC 21130-074

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Acetaminophen Aspirin And Caffeine (NDC 21130-074). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Better Living Brands, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (250 mg/250 mg/65 mg Container Label)

Drug Facts text panels for Acetaminophen, Aspirin, and Caffeine tablets, film coated, 250 mg/250 mg/65 mg. The panels include active ingredients, purposes, warnings, allergy alerts, directions, use instructions, and other drug information. The label highlights migraine relief, overdose warnings, and advises consultation with a healthcare provider as needed. Provided by Better Living Brands LLC.*

FDA Label Image

Package Label-principal Display Panel (250 mg/250 mg/65 mg Container Carton Label)

Packaging label for ACETAMINOPHEN ASPIRIN AND CAFFEINE Migraine Relief tablets by Better Living Brands, LLC. The film-coated oral tablets contain 250 mg acetaminophen, 250 mg aspirin, and 65 mg caffeine per tablet. The carton displays drug facts, usage warnings, inactive ingredients, and a depiction of an actual tablet. Package contains 24 tablets.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.